PortfoliosLab logo

Anika Therapeutics, Inc. (ANIK)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Anika Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $82,057 for a total return of roughly 720.57%. All prices are adjusted for splits and dividends.

ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANIK

Anika Therapeutics, Inc.


Anika Therapeutics, Inc. had a return of -2.97% year-to-date (YTD) and 13.83% in the last 12 months. Over the past 10 years, Anika Therapeutics, Inc. had an annualized return of 7.01%, while the S&P 500 had an annualized return of 10.16%, indicating that Anika Therapeutics, Inc. did not perform as well as the benchmark.

1 month-9.40%3.51%
6 months22.68%12.88%
1 year13.83%-10.71%
5 years (annualized)-10.40%9.25%
10 years (annualized)7.01%10.16%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anika Therapeutics, Inc. Sharpe ratio is 0.33. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.

ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Anika Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Anika Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anika Therapeutics, Inc. is 95.88%, recorded on Dec 26, 2000. It took 1642 trading sessions for the portfolio to recover.



To Bottom


To Recover



-95.88%Jul 15, 1998620Dec 26, 20001642Jul 25, 20072262
-86.24%Sep 24, 2007321Dec 30, 20081154Aug 1, 20131475
-72.19%Oct 28, 2019638May 9, 2022
-68.42%May 13, 1993395Dec 16, 1994336May 3, 1996731
-57.96%Jan 30, 201899Jun 20, 2018340Oct 25, 2019439
-54.92%May 20, 1996144Dec 17, 1996174Aug 28, 1997318
-37.83%Jul 15, 2014306Sep 29, 2015185Jun 23, 2016491
-30.95%Dec 11, 199734Jan 30, 199847Apr 8, 199881
-24.37%Jan 17, 201411Feb 3, 201416Feb 26, 201427
-23.63%Jul 5, 201687Nov 3, 2016210Sep 6, 2017297

Volatility Chart

Current Anika Therapeutics, Inc. volatility is 28.11%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)